Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Pastan

Showing results (41-50 of 340) with videos related to

Pageof 34
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2007
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumorsYujian Zhang, Laiman Xiang, Raffit Hassan, et al.
Cancer Research|May 8, 2012
Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumorsYoungshang Pak, Yujian Zhang, Ira Pastan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2011
Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibodyXing Du, Laiman Xiang, Crystal Mackall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphineTakatoshi Hikida, Yasuji Kitabatake, Ira Pastan, et al.
Clinical Chemistry and Laboratory Medicine|May 10, 2006
Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human seraTomoko Ise, Robert J Kreitman, Ira Pastan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cellsKevin Hollevoet, Antonella Antignani, David J Fitzgerald, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2022
Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structuresWenlong Liu, Chin-Hsien Tai, Xiufen Liu, et al.
Plos One|March 25, 2015
Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell lineKevin Hollevoet, Emily Mason-Osann, Fabian Müller, et al.
Endocrinology|July 17, 2003
Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoterWing-Shing Cheng, Valeria Giandomenico, Ira Pastan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant ImmunotoxinEmily M King, Ronit Mazor, Nicolas Çuburu, et al.
Pageof 34

Showing results (41-50 of 340) with videos related to

Sort By:
Pageof 34
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2007
Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumorsYujian Zhang, Laiman Xiang, Raffit Hassan, et al.
Cancer Research|May 8, 2012
Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumorsYoungshang Pak, Yujian Zhang, Ira Pastan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2011
Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibodyXing Du, Laiman Xiang, Crystal Mackall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphineTakatoshi Hikida, Yasuji Kitabatake, Ira Pastan, et al.
Clinical Chemistry and Laboratory Medicine|May 10, 2006
Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human seraTomoko Ise, Robert J Kreitman, Ira Pastan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cellsKevin Hollevoet, Antonella Antignani, David J Fitzgerald, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2022
Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structuresWenlong Liu, Chin-Hsien Tai, Xiufen Liu, et al.
Plos One|March 25, 2015
Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell lineKevin Hollevoet, Emily Mason-Osann, Fabian Müller, et al.
Endocrinology|July 17, 2003
Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoterWing-Shing Cheng, Valeria Giandomenico, Ira Pastan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant ImmunotoxinEmily M King, Ronit Mazor, Nicolas Çuburu, et al.
Pageof 34